ADAM17 and colonic neoplasm: Our data provide evidence that overall colon cancer-associated ADAM17 variants in the MPD and CD lack sufficient cell surface trafficking, but vary only slightly in their proteolytic activity in comparison to the wildtype (wt) construct.